Results 111 to 120 of about 25,975 (242)
ABSTRACT Background Metabolic syndrome (MetS) is a prevalent cardiometabolic disorder characterized by central obesity, insulin resistance, dyslipidemia, and hypertension. Microbiome‐targeted therapies with probiotics, prebiotics, and synbiotics may improve outcomes by modulating metabolism, inflammation, and blood pressure.
Pradipta Paul +3 more
wiley +1 more source
ABSTRACT Obesity arises from intertwined and reciprocal diet‐microbiome‐host pathways that reshape energy balance, insulin sensitivity, and inflammation. This review synthesizes mechanistic links between microbial functions and metabolic control, charts lifestyle‐related lifecourse dynamics from birth to older age, examines how GLP‐1‐based therapies ...
Ioanna Panagiota Kalafati +12 more
wiley +1 more source
Of mice and men—The emerging oral–gut–brain axis of health and disease
Abstract Objectives Oral health's inextricable links to systemic health are highlighted by the emerging oral–gut–brain axis and other well‐known axes. There is growing evidence of a complex oral–gut–brain axis linking mouth and gut microbiomes with the central nervous system.
Yvonne L. Hernandez‐Kapila +1 more
wiley +1 more source
Periodontitis and metabolic dysfunction‐associated steatotic liver disease
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon +6 more
wiley +1 more source
Translating gut microbiome research into therapies for type 1 diabetes
Abstract Type 1 diabetes (T1D) is characterised by the loss of functional pancreatic β‐cells, for which lifelong insulin therapy remains the standard of care. Given that the gut microbiome can influence host health and that shifts in gut microbial profiles have been observed in T1D, growing interest has emerged in the role of the gut microbiome in T1D,
Shanti P. Kok +2 more
wiley +1 more source
Structural limits of decision attribution in modular automated governance systems
Abstract Modular automated governance systems increasingly coordinate distributed decision‐making across multiple agents. In blockchain‐based DAOs and automated on‐chain deployment pipelines, all state transitions are publicly observable. This transparency is frequently equated with accountability. We challenge this assumption. We argue that in certain
Manuele Tele Junior Fernandez
wiley +1 more source
Abstract Multi‐agent systems (MAS)—a uniquely important subset of the wider field commonly called “Agentic AI”—enable complex work processes involving distributed networks of multiple AIs, people, and technology tools. However, they also carry big risks. Root causes of catastrophic safety failures in multi‐agent collaboration (as in human collaboration)
Jeffrey M. Bradshaw +22 more
wiley +1 more source
Comparison of the FMT assay with the Cell Painting approach in healthy patient derived fibroblasts [PDF]
Hohensee Tabea, Edfeldt Fredrik
doaj +1 more source
Fluorine-Mediated Molten-Salt Crystallization Regulates Phase Evolution and Structural Stability in Sodium Layered Oxides. [PDF]
Shi C +24 more
europepmc +1 more source

